Notably, rTMS inhibits BACE1 expression and increases the ratio of insulin-degrading enzyme (IDE) [173,174], improving both the production and clearance of amyloid load by enhancing brain drainage pathways [174]. The gene discussed is IDE; the disease is amyloidosis.